Skip to main content
Figure 3 | Lipids in Health and Disease

Figure 3

From: Treatment of an adrenomyeloneuropathy patient with Lorenzo's oil and supplementation with docosahexaenoic acid-A case report

Figure 3

Omega 3 PUFA RBC analysis of the AMN patient where (a) depicts the concentrations of EPA; (b) depicts the concentrations of DHA and (c) the ratio of DPA/EPA for the period of September 2008 to April 2009. The black circle, (October 2008), represents one month after DHA supplementation was started. The grey dashed line indicates the average value of control samples collected.

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X